The method of deriving human T-cell clones alters the proportion of IL-10-producing cells

被引:13
作者
Cohen, SBA [1 ]
Webb, LMC [1 ]
Feldmann, M [1 ]
机构
[1] KENNEDY INST,LONDON,ENGLAND
关键词
D O I
10.1046/j.1365-2567.1996.503575.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is now well documented that the mode of primary stimulation in the mouse determines the ratio of Th1-, Th0- or Th2-type T cells obtained. In this paper we determine whether driving and cloning human peripheral blood mononuclear cells (PBMC) non-specifically with interleukin-2 (IL-2) and/or IL-4 and mitogen, will differentially select T cells for IL-10 production. The presence of IL-2 during culture (with or without IL-4) yielded predominantly Th1-type clones (81% of clones with IL-2 alone and 77% with IL-2 + IL-4) and a low frequency of Th0-type clones (19% of clones with IL-2 and 10% of clones with IL-2 + IL-4), whereas IL-4 alone increased the yield of the IL-4 producing Th0 (35%) clones. The proportions of IL-2-producing clones did not alter with treatment; however, the combination of IL-2 + IL-4 altered the proportions of IL-10-producing clones. 47% of IL-2-cultured cells and 51% of IL-4-cultured cells produced IL-10 respectively, whereas only 22% of clones driven with IL-2 + IL-4 produced detectable levels of IL-10. Thus in the preliminary experiments described here we have demonstrated that the cytokines used to initially drive out human T cells and maintain the T-cell growth can skew the Th1/Th2/Th0 cytokine profiles of the clones obtained from mitogen-stimulated cultures. Moreover and unexpectedly the proportion of IL-10-producing cells is altered. These results are important in interpreting analysis of the cytokine profiles of human T cells and raise questions concerning how we should derive T-cell clones for a cytokine analysis that truly reflects the in vivo situation.
引用
收藏
页码:343 / 347
页数:5
相关论文
共 17 条
[1]  
BROOKES SM, 1995, IN PRESS CLIN EXP IM
[2]   HIGH-LEVEL OF INTERLEUKIN-10 PRODUCTION BY THE ACTIVATED T-CELL POPULATION WITHIN THE RHEUMATOID SYNOVIAL-MEMBRANE [J].
COHEN, SBA ;
KATSIKIS, PD ;
CHU, CQ ;
THOMSSEN, H ;
WEBB, LMC ;
MAINI, RN ;
LONDEI, M ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1995, 38 (07) :946-952
[3]  
CORREALE J, 1995, J IMMUNOL, V154, P2959
[4]  
DELPRETE G, 1993, J IMMUNOL, V150, P353
[5]   LYMPHOKINE-MEDIATED REGULATION OF THE PROLIFERATIVE RESPONSE OF CLONES OF T-HELPER-1 AND T-HELPER-2 CELLS [J].
FERNANDEZBOTRAN, R ;
SANDERS, VM ;
MOSMANN, TR ;
VITETTA, ES .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02) :543-558
[6]  
GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245
[7]   ARE CD4(+) T(H)1 CELLS PRO-INFLAMMATORY OR ANTIINFLAMMATORY - THE RATIO OF IL-10 TO IFN-GAMMA OR IL-2 DETERMINES THEIR FUNCTION [J].
KATSIKIS, PD ;
COHEN, SBA ;
LONDEI, M ;
FELDMANN, M .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (08) :1287-1294
[8]   CD28 ACTIVATION PROMOTES TH2 SUBSET DIFFERENTIATION BY HUMAN CD4(+) CELLS [J].
KING, CL ;
STUPI, RJ ;
CRAIGHEAD, N ;
JUNE, CH ;
THYPHRONITIS, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (02) :587-595
[9]   T-CELLS CLONED FROM HUMAN RHEUMATOID SYNOVIAL-MEMBRANE FUNCTIONALLY REPRESENT THE TH1 SUBSET [J].
MILTENBURG, AMM ;
VANLAAR, JM ;
DEKUIPER, R ;
DAHA, MR ;
BREEDVELD, FC .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 35 (05) :603-610
[10]  
MOCCI S, 1995, J IMMUNOL, V154, P3779